India to Switzerland: Osimertinib Export Trade Route

The India to Switzerland Osimertinib corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $15.0K USD. The route is dominated by VAMA HEALTH WORLD LLP, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's osimertinib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $15.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with osimertinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 19.1%, placing it at rank #8 among India's top osimertinib export destinations globally.

On the import side, key buyers of Indian osimertinib in Switzerland include AS PER INVOICE AS. AS PER INVOICE AS is the single largest importer with 1 shipments valued at $15.0K USD.

India's osimertinib exports to Switzerland are driven primarily by a handful of large-scale manufacturers. VAMA HEALTH WORLD LLP with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Switzerland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA HEALTH WORLD LLP — together account for 100% of total trade value on this route. The average shipment value of $15.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, AS PER INVOICE AS is the largest importer with 1 shipments worth $15.0K USD — representing 100% of all osimertinib imports from India on this route.